Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

NCT00515970 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00515970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00515970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Suspended
Start date
December 31, 2007
Completion date
December 31, 2014
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell